Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16

Yu Tang Tung, Pin Wu Huang, Yu Ching Chou, Cheng Wei Lai, Hsiu Po Wang, Heng Chien Ho, Chih Ching Yen, Chih Yen Tu, Tung Chou Tsai, Dah Cherng Yeh, Jiun Long Wang, Kowit Yu Chong, Chuan Mu Chen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Many studies have shown that vascular endothelial growth factor (VEGF), especially the human VEGF-A165 (hVEGF-A165) isoform, is a key proangiogenic factor that is overexpressed in lung cancer. We generated transgenic mice that overexpresses hVEGF-A165 in lung-specific Clara cells to investigate the development of pulmonary adenocarcinoma. In this study, three transgenic mouse strains were produced by pronuclear microinjection, and Southern blot analysis indicated similar patterns of the foreign gene within the genomes of the transgenic founder mice and their offspring. Accordingly, hVegf-A165 mRNA was expressed specifically in the lung tissue of the transgenic mice. Histopathological examination of the lung tissues of the transgenic mice showed that hVEGF-A165 overexpression induced bronchial inflammation, fibrosis, cysts, and adenoma. Pathological section and magnetic resonance imaging (MRI) analyses demonstrated a positive correlation between the development of pulmonary cancer and hVEGF expression levels, which were determined by immunohistochemistry, qRT-PCR, and western blot analyses. Gene expression profiling by cDNA microarray revealed a set of up-regulated genes (hvegf-A165, cyclin b1, cdc2, egfr, mmp9, nrp-1, and kdr) in VEGF tumors compared with wild-type lung tissues. In addition, overexpressing hVEGF-A165 in Clara cells increases CD105, fibrogenic genes (collagen α1, α-SMA, TGF-β1, and TIMP1), and inflammatory cytokines (IL-1, IL-6, and TNF-α) in the lungs of hVEGF-A165-overexpressing transgenic mice as compared to wild-type mice. We further demonstrated that the intranasal administration of microRNA-16 (miR-16) inhibited lung tumor growth by suppressing VEGF expression via the intrinsic and extrinsic apoptotic pathways. In conclusion, hVEGF-A165 transgenic mice exhibited complex alterations in gene expression and tumorigenesis and may be a relevant model for studying VEGFtargeted therapies in lung adenocarcinoma.

Original languageEnglish
Pages (from-to)10222-10238
Number of pages17
JournalOncotarget
Volume6
Issue number12
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

MicroRNAs
Transgenic Mice
Carcinogenesis
Lung
Neoplasms
Vascular Endothelial Growth Factor A
Lung Neoplasms
Genes
Cyclin B1
Intranasal Administration
Microinjections
Gene Expression Profiling
Southern Blotting
human VEGFA protein
Oligonucleotide Array Sequence Analysis
Interleukin-1
Adenoma
Cysts
Interleukin-6
Protein Isoforms

Keywords

  • Magnetic resonance imaging (MRI)
  • miRNA therapy
  • Pulmonary tumorigenesis
  • Transgenic mice
  • VEGF

ASJC Scopus subject areas

  • Oncology

Cite this

Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16. / Tung, Yu Tang; Huang, Pin Wu; Chou, Yu Ching; Lai, Cheng Wei; Wang, Hsiu Po; Ho, Heng Chien; Yen, Chih Ching; Tu, Chih Yen; Tsai, Tung Chou; Yeh, Dah Cherng; Wang, Jiun Long; Chong, Kowit Yu; Chen, Chuan Mu.

In: Oncotarget, Vol. 6, No. 12, 2015, p. 10222-10238.

Research output: Contribution to journalArticle

Tung, YT, Huang, PW, Chou, YC, Lai, CW, Wang, HP, Ho, HC, Yen, CC, Tu, CY, Tsai, TC, Yeh, DC, Wang, JL, Chong, KY & Chen, CM 2015, 'Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16', Oncotarget, vol. 6, no. 12, pp. 10222-10238.
Tung, Yu Tang ; Huang, Pin Wu ; Chou, Yu Ching ; Lai, Cheng Wei ; Wang, Hsiu Po ; Ho, Heng Chien ; Yen, Chih Ching ; Tu, Chih Yen ; Tsai, Tung Chou ; Yeh, Dah Cherng ; Wang, Jiun Long ; Chong, Kowit Yu ; Chen, Chuan Mu. / Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16. In: Oncotarget. 2015 ; Vol. 6, No. 12. pp. 10222-10238.
@article{207fbc385c614fac895f0eb9e55bf904,
title = "Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16",
abstract = "Many studies have shown that vascular endothelial growth factor (VEGF), especially the human VEGF-A165 (hVEGF-A165) isoform, is a key proangiogenic factor that is overexpressed in lung cancer. We generated transgenic mice that overexpresses hVEGF-A165 in lung-specific Clara cells to investigate the development of pulmonary adenocarcinoma. In this study, three transgenic mouse strains were produced by pronuclear microinjection, and Southern blot analysis indicated similar patterns of the foreign gene within the genomes of the transgenic founder mice and their offspring. Accordingly, hVegf-A165 mRNA was expressed specifically in the lung tissue of the transgenic mice. Histopathological examination of the lung tissues of the transgenic mice showed that hVEGF-A165 overexpression induced bronchial inflammation, fibrosis, cysts, and adenoma. Pathological section and magnetic resonance imaging (MRI) analyses demonstrated a positive correlation between the development of pulmonary cancer and hVEGF expression levels, which were determined by immunohistochemistry, qRT-PCR, and western blot analyses. Gene expression profiling by cDNA microarray revealed a set of up-regulated genes (hvegf-A165, cyclin b1, cdc2, egfr, mmp9, nrp-1, and kdr) in VEGF tumors compared with wild-type lung tissues. In addition, overexpressing hVEGF-A165 in Clara cells increases CD105, fibrogenic genes (collagen α1, α-SMA, TGF-β1, and TIMP1), and inflammatory cytokines (IL-1, IL-6, and TNF-α) in the lungs of hVEGF-A165-overexpressing transgenic mice as compared to wild-type mice. We further demonstrated that the intranasal administration of microRNA-16 (miR-16) inhibited lung tumor growth by suppressing VEGF expression via the intrinsic and extrinsic apoptotic pathways. In conclusion, hVEGF-A165 transgenic mice exhibited complex alterations in gene expression and tumorigenesis and may be a relevant model for studying VEGFtargeted therapies in lung adenocarcinoma.",
keywords = "Magnetic resonance imaging (MRI), miRNA therapy, Pulmonary tumorigenesis, Transgenic mice, VEGF",
author = "Tung, {Yu Tang} and Huang, {Pin Wu} and Chou, {Yu Ching} and Lai, {Cheng Wei} and Wang, {Hsiu Po} and Ho, {Heng Chien} and Yen, {Chih Ching} and Tu, {Chih Yen} and Tsai, {Tung Chou} and Yeh, {Dah Cherng} and Wang, {Jiun Long} and Chong, {Kowit Yu} and Chen, {Chuan Mu}",
year = "2015",
language = "English",
volume = "6",
pages = "10222--10238",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "12",

}

TY - JOUR

T1 - Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16

AU - Tung, Yu Tang

AU - Huang, Pin Wu

AU - Chou, Yu Ching

AU - Lai, Cheng Wei

AU - Wang, Hsiu Po

AU - Ho, Heng Chien

AU - Yen, Chih Ching

AU - Tu, Chih Yen

AU - Tsai, Tung Chou

AU - Yeh, Dah Cherng

AU - Wang, Jiun Long

AU - Chong, Kowit Yu

AU - Chen, Chuan Mu

PY - 2015

Y1 - 2015

N2 - Many studies have shown that vascular endothelial growth factor (VEGF), especially the human VEGF-A165 (hVEGF-A165) isoform, is a key proangiogenic factor that is overexpressed in lung cancer. We generated transgenic mice that overexpresses hVEGF-A165 in lung-specific Clara cells to investigate the development of pulmonary adenocarcinoma. In this study, three transgenic mouse strains were produced by pronuclear microinjection, and Southern blot analysis indicated similar patterns of the foreign gene within the genomes of the transgenic founder mice and their offspring. Accordingly, hVegf-A165 mRNA was expressed specifically in the lung tissue of the transgenic mice. Histopathological examination of the lung tissues of the transgenic mice showed that hVEGF-A165 overexpression induced bronchial inflammation, fibrosis, cysts, and adenoma. Pathological section and magnetic resonance imaging (MRI) analyses demonstrated a positive correlation between the development of pulmonary cancer and hVEGF expression levels, which were determined by immunohistochemistry, qRT-PCR, and western blot analyses. Gene expression profiling by cDNA microarray revealed a set of up-regulated genes (hvegf-A165, cyclin b1, cdc2, egfr, mmp9, nrp-1, and kdr) in VEGF tumors compared with wild-type lung tissues. In addition, overexpressing hVEGF-A165 in Clara cells increases CD105, fibrogenic genes (collagen α1, α-SMA, TGF-β1, and TIMP1), and inflammatory cytokines (IL-1, IL-6, and TNF-α) in the lungs of hVEGF-A165-overexpressing transgenic mice as compared to wild-type mice. We further demonstrated that the intranasal administration of microRNA-16 (miR-16) inhibited lung tumor growth by suppressing VEGF expression via the intrinsic and extrinsic apoptotic pathways. In conclusion, hVEGF-A165 transgenic mice exhibited complex alterations in gene expression and tumorigenesis and may be a relevant model for studying VEGFtargeted therapies in lung adenocarcinoma.

AB - Many studies have shown that vascular endothelial growth factor (VEGF), especially the human VEGF-A165 (hVEGF-A165) isoform, is a key proangiogenic factor that is overexpressed in lung cancer. We generated transgenic mice that overexpresses hVEGF-A165 in lung-specific Clara cells to investigate the development of pulmonary adenocarcinoma. In this study, three transgenic mouse strains were produced by pronuclear microinjection, and Southern blot analysis indicated similar patterns of the foreign gene within the genomes of the transgenic founder mice and their offspring. Accordingly, hVegf-A165 mRNA was expressed specifically in the lung tissue of the transgenic mice. Histopathological examination of the lung tissues of the transgenic mice showed that hVEGF-A165 overexpression induced bronchial inflammation, fibrosis, cysts, and adenoma. Pathological section and magnetic resonance imaging (MRI) analyses demonstrated a positive correlation between the development of pulmonary cancer and hVEGF expression levels, which were determined by immunohistochemistry, qRT-PCR, and western blot analyses. Gene expression profiling by cDNA microarray revealed a set of up-regulated genes (hvegf-A165, cyclin b1, cdc2, egfr, mmp9, nrp-1, and kdr) in VEGF tumors compared with wild-type lung tissues. In addition, overexpressing hVEGF-A165 in Clara cells increases CD105, fibrogenic genes (collagen α1, α-SMA, TGF-β1, and TIMP1), and inflammatory cytokines (IL-1, IL-6, and TNF-α) in the lungs of hVEGF-A165-overexpressing transgenic mice as compared to wild-type mice. We further demonstrated that the intranasal administration of microRNA-16 (miR-16) inhibited lung tumor growth by suppressing VEGF expression via the intrinsic and extrinsic apoptotic pathways. In conclusion, hVEGF-A165 transgenic mice exhibited complex alterations in gene expression and tumorigenesis and may be a relevant model for studying VEGFtargeted therapies in lung adenocarcinoma.

KW - Magnetic resonance imaging (MRI)

KW - miRNA therapy

KW - Pulmonary tumorigenesis

KW - Transgenic mice

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84929590499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929590499&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 10222

EP - 10238

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 12

ER -